Greenwich LifeSciences, Inc. Profile Avatar - Palmy Investing

Greenwich LifeSciences, Inc.

Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which h…

Biotechnology
US, Stafford [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
0.00% YoY
0.00% 3Yr
0.00% 5Yr
0.00% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Download
Cash Amount Pay Date
Download
Cash Amount Pay Date
End of GLSI's Analysis
CIK: 1799788 CUSIP: 396879108 ISIN: US3968791083 LEI: - UEI: -
Secondary Listings
GLSI has no secondary listings inside our databases.